Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Compounding Pharmacy includes pharmaceutical ingredient alteration (PIA), pharmaceutical application alteration (PAA), currently unavailable pharmaceutical manufacturing (CUPM), pharmaceutical dosage alteration (PDA) and specialized animal pharmaceutical manufacturing (SAPM), the proportion of Pharmaceutical ingredient alteration (PIA) in 2018 is about 34.6%.
The classification of Compounding Pharmacy includes pharmaceutical ingredient alteration (PIA), pharmaceutical application alteration (PAA), currently unavailable pharmaceutical manufacturing (CUPM), pharmaceutical dosage alteration (PDA) and specialized animal pharmaceutical manufacturing (SAPM), the proportion of Pharmaceutical ingredient alteration (PIA) in 2018 is about 34.6%.
Market Analysis and Insights: Global Compounding Pharmacy Market
In 2019, the global Compounding Pharmacy market size was US$ 11180 million and it is expected to reach US$ 13500 million by the end of 2026, with a CAGR of 2.7% during 2021-2026.
Global Compounding Pharmacy Scope and Market Size
Compounding Pharmacy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Compounding Pharmacy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Compounding Pharmacy market is segmented into PIA, PAA, CUPM, PDA, SAPM, etc.
Segment by Application, the Compounding Pharmacy market is segmented into Consumers Aged 18 and Younger, Consumers Aged 19 to 44, Consumers Aged 45 to 64, Consumers Aged 65 and Older, etc.
Regional and Country-level Analysis
The Compounding Pharmacy market is analysed and market size information is provided by regions (countries).
The key regions covered in the Compounding Pharmacy market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Compounding Pharmacy market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Compounding Pharmacy business, the date to enter into the Compounding Pharmacy market, Compounding Pharmacy product introduction, recent developments, etc.
The major vendors include PharMEDium Services, B. Braun Group, Fagron, Wedgewood Pharmacy, New Compounding Pharma, Medisca, Fresenius Kabi, Advanced Pharma, AIN GROUP, Nihon Chouzai, Sogo Medical, Dougherty’s Pharmacy, Apollo Pharmacy, Downing Labs, Qol Holdings, Olympia Pharmacy, PUMCH, Triangle Compounding Pharmacy, Peking University First Hospital, Affiliated Hospital of Guangdong Public Institution of Medicine, Lorraine's Pharmacy, PLAGH, Institutional Pharmacy Solutions, Ruijin Hospital, etc.
This report focuses on the global Compounding Pharmacy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Compounding Pharmacy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
PharMEDium Services
B. Braun Group
Fagron
Wedgewood Pharmacy
New Compounding Pharma
Medisca
Fresenius Kabi
Advanced Pharma
AIN GROUP
Nihon Chouzai
Sogo Medical
Dougherty’s Pharmacy
Apollo Pharmacy
Downing Labs
Qol Holdings
Olympia Pharmacy
PUMCH
Triangle Compounding Pharmacy
Peking University First Hospital
Affiliated Hospital of Guangdong Public Institution of Medicine
Lorraine's Pharmacy
PLAGH
Institutional Pharmacy Solutions
Ruijin Hospital
PIA
PAA
CUPM
PDA
SAPM
Consumers Aged 18 and Younger
Consumers Aged 19 to 44
Consumers Aged 45 to 64
Consumers Aged 65 and Older
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
To analyze global Compounding Pharmacy status, future forecast, growth opportunity, key market and key players.
To present the Compounding Pharmacy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Compounding Pharmacy are as follows:
History Year: 2015-2019
2019
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
The classification of Compounding Pharmacy includes pharmaceutical ingredient alteration (PIA), pharmaceutical application alteration (PAA), currently unavailable pharmaceutical manufacturing (CUPM), pharmaceutical dosage alteration (PDA) and specialized animal pharmaceutical manufacturing (SAPM), the proportion of Pharmaceutical ingredient alteration (PIA) in 2018 is about 34.6%.
Market Analysis and Insights: Global Compounding Pharmacy Market
In 2019, the global Compounding Pharmacy market size was US$ 11180 million and it is expected to reach US$ 13500 million by the end of 2026, with a CAGR of 2.7% during 2021-2026.
Global Compounding Pharmacy Scope and Market Size
Compounding Pharmacy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Compounding Pharmacy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Compounding Pharmacy market is segmented into PIA, PAA, CUPM, PDA, SAPM, etc.
Segment by Application, the Compounding Pharmacy market is segmented into Consumers Aged 18 and Younger, Consumers Aged 19 to 44, Consumers Aged 45 to 64, Consumers Aged 65 and Older, etc.
Regional and Country-level Analysis
The Compounding Pharmacy market is analysed and market size information is provided by regions (countries).
The key regions covered in the Compounding Pharmacy market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Competitive Landscape
and Compounding Pharmacy Market Share AnalysisCompounding Pharmacy market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Compounding Pharmacy business, the date to enter into the Compounding Pharmacy market, Compounding Pharmacy product introduction, recent developments, etc.
The major vendors include PharMEDium Services, B. Braun Group, Fagron, Wedgewood Pharmacy, New Compounding Pharma, Medisca, Fresenius Kabi, Advanced Pharma, AIN GROUP, Nihon Chouzai, Sogo Medical, Dougherty’s Pharmacy, Apollo Pharmacy, Downing Labs, Qol Holdings, Olympia Pharmacy, PUMCH, Triangle Compounding Pharmacy, Peking University First Hospital, Affiliated Hospital of Guangdong Public Institution of Medicine, Lorraine's Pharmacy, PLAGH, Institutional Pharmacy Solutions, Ruijin Hospital, etc.
This report focuses on the global Compounding Pharmacy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Compounding Pharmacy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
PharMEDium Services
B. Braun Group
Fagron
Wedgewood Pharmacy
New Compounding Pharma
Medisca
Fresenius Kabi
Advanced Pharma
AIN GROUP
Nihon Chouzai
Sogo Medical
Dougherty’s Pharmacy
Apollo Pharmacy
Downing Labs
Qol Holdings
Olympia Pharmacy
PUMCH
Triangle Compounding Pharmacy
Peking University First Hospital
Affiliated Hospital of Guangdong Public Institution of Medicine
Lorraine's Pharmacy
PLAGH
Institutional Pharmacy Solutions
Ruijin Hospital
Market segment by Type, the product can be split into
PIA
PAA
CUPM
PDA
SAPM
Market segment by Application, split into
Consumers Aged 18 and Younger
Consumers Aged 19 to 44
Consumers Aged 45 to 64
Consumers Aged 65 and Older
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Compounding Pharmacy status, future forecast, growth opportunity, key market and key players.
To present the Compounding Pharmacy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Compounding Pharmacy are as follows:
History Year: 2015-2019
Base Year:
2019Estimated Year:
2020Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
